What are the factors driving antimicrobial resistance? Perspectives from a public event in London, England

BMC Infectious Diseases

Volumn 16, Issue 1, 2016, Pages

  Castro Sánchez, Enrique ^a   Moore, Luke S P ^a,b   Husson, Fran ^c   Holmes, Alison H ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

Antimicrobial resistance; Health literacy; Public awareness

Indexed keywords

ANTIBIOTIC RESISTANCE; ARTICLE; DIAGNOSTIC TEST; DRUG EFFICACY; DRUG MISUSE; ENGLAND; HEALTH SURVEY; HUMAN; PUBLIC HEALTH; RISK FACTOR; VACCINATION; ANIMAL; PUBLIC OPINION;

ANTIINFECTIVE AGENT;

ANIMALS; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; HUMANS; LONDON; PRESCRIPTION DRUG MISUSE; PUBLIC OPINION;

EID: 84985021337     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-016-1810-x     Document Type: Article

References (34)

1. Laxminarayan R, Matsoso P, Pant S, et al. Access to effective antimicrobials: a worldwide challenge. Lancet. 2015. doi: 10.1016/S0140-6736(15)00474-2.
2. Dar OA, Hasan R, Schlundt J, et al. Exploring the evidence base for national and regional policy interventions to combat resistance. Lancet. 2015. doi: 10.1016/S0140-6736(15)00520-6.
3. Planta MB. The role of poverty in antimicrobial resistance. J Am Board Fam Med. 2007;20:533-9.
4. Hawkings NJ, Butler CC, Wood F. Antibiotics in the community: a typology of user behaviours. Patient Educ Couns. 2008;73:146-52.
5. Smith RA, Quesnell M, Glick L, Hackman N, M'Ikanatha NM. Preparing for antibiotic resistance campaigns: a person-centered approach to audience segmentation. J Health Commun. 2015;20:1433-40. doi: 10.1080/10810730.2015.1018652.
6. Francis NA, Butler CC, Hood K, Simpson S, Wood F, Nuttall J. Effect of using an interactive booklet about childhood respiratory tract infections in primary care consultations on reconsulting and antibiotic prescribing: a cluster randomised controlled trial. BMJ. 2009;339:b2885.
7. de Bont EG, Alink M, Falkenberg FC, Dinant GJ, Cals JW. Patient information leaflets to reduce antibiotic use and reconsultation rates in general practice: a systematic review. BMJ Open. 2015;5(6):e007612. doi: 10.1136/bmjopen-2015-007612.
8. Public Health England. Local action on health inequalities Improving health literacy to reduce health inequalities. 2015. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/460709/4a_Health_Literacy-Full.pdf. Accessed 14 Nov 2015.
9. Rubina GJ, Finna Y, Potts HW, Michie S. Who is sceptical about emerging public health threats? Results from 39 national surveys in the United Kingdom. Public Health. 2015. doi: 10.1016/j.puhe.2015.09.004.
10. WHO. Antibiotic resistance: multi-country public awareness survey. Geneva: WHO; 2015.
11. Holmes AH, Moore LS, Sundsfjord A, et al. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet. 2015. doi: 10.1016/S0140-6736(15)00473-0.
12. Goossens H, Ferech M, Vander Stichele R, et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365:579-87.
13. Zhang YB, Li Y, Sun XL. Antibiotic resistance of bacteria isolated from shrimp hatcheries and cultural ponds on Donghai Island, China. Mar Pollut Bull. 2011;62:2299-307.
14. Food and Drug Administration. 2011 Summary report on antimicrobials sold or distributed for use in food-producing animals. 2014. http://www.fda.gov/downloads/ForIndustry/UserFees/AnimalDrugUserFeeActADUFA/UCM338170.pdf. Accessed 18 Nov 2015.
15. Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010;10:597-602.
16. Bedford T, Riley S, Barr IG, et al. Global circulation patterns of seasonal influenza viruses vary with antigenic drift. Nature. 2015;523:217-20. doi: 10.1038/nature14460.
17. Pai MP. Treatment of bacterial infections in obese adult patients: how to appropriately manage antimicrobial dosage. Curr Opin Pharmacol. 2015;24:12-7. doi: 10.1016/j.coph.2015.06.004.
18. Newton PN, Green MD, Fernández FM, Day NPJ, White NJ. Counterfeit anti-infective drugs. Lancet Infect Dis. 2006;6:602-13.
19. Done HY, Halden RU. Reconnaissance of 47 antibiotics and associated microbial risks in seafood sold in the United States. J Hazard Mater. 2015;282:10-7. doi: 10.1016/j.jhazmat.2014.08.075.
20. Mitjà O, Houinei W, Moses P, et al. Mass treatment with single-dose azithromycin for yaws. N Engl J Med. 2015;372(8):703-10. doi: 10.1056/NEJMoa1408586.
21. West SK, Moncada J, Munoz B, et al. Is there evidence for resistance of ocular Chlamydia trachomatis to azithromycin after mass treatment for trachoma control? J Infect Dis. 2014;1:65-71.
22. Coles CL, Mabula K, Seidman JC, et al. Mass distribution of azithromycin for trachoma control is associated with increased risk of azithromycin-resistant Streptococcus pneumoniae carriage in young children 6 months after treatment. Clin Infect Dis. 2013;56:1519-26. doi: 10.1093/cid/cit137.
23. McNulty CAM, Boyle P, Nichols T, et al. The public's attitudes to and compliance with antibiotics. J Antimicrob Chemother. 2007;60 Suppl 1:i63-8.
24. WHO. Worldwide country situation analysis: response to antimicrobial resistance. 2015. http://apps.who.int/iris/bitstream/10665/163468/1/9789241564946_eng.pdf?ua=1. Accessed 1 Nov 2015.
25. Lambert MF, Masters GA, Brent SL. Can mass media campaigns change antimicrobial prescribing? A regional evaluation study. J Antimicrob Chemother. 2007;59:537-43.
26. Huttner B, Goossens H, Verheij T, et al. on behalf of the CHAMP consortium. Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. Lancet Infect Dis. 2010;10:17-31.
27. Dyar OJ, Castro-Sánchez E, Holmes AH. What makes people talk about antibiotics on social media? A retrospective analysis of Twitter use. J Antimicrob Chemother. 2014;69(9):2568-72. doi: 10.1093/jac/dku165.
28. Wellcome Trust. Exploring the consumer perspective on antimicrobial resistance. 2015. http://wellcomelibrary.org/item/b24978000. Accessed 1 Nov 2015.
29. Sørensen K, Pelikan JM, Röthlin F, et al. Health literacy in Europe: comparative results of the European health literacy survey (HLS-EU). Eur J Public Health. 2015;25(6):1053-8. doi: 10.1093/eurpub/ckv043. Epub 2015 Apr 5.
30. Castro-Sánchez E, Chang PW, Vila-Candel R, Escobedo AA, Holmes AH. Health literacy and infectious diseases: Why does it matter? Int J Infect Dis. 2016. doi: 10.1016/j.ijid.2015.12.019.
31. National Institute for Health and Care Excellence. Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use. 2015. http://www.nice.org.uk/guidance/ng15/evidence/full-guideline-252320797. Accessed 9 Nov 2015.
32. Jasper Littmann J, Viens AM. The ethical significance of antimicrobial resistance. Public Health Ethics. 2015. doi: 10.1093/phe/phv025.
33. EC Directorate-General for Health and Consumers, Special Eurobarometer 407. Antimicrobial resistance. 2013. http://www.ab.gov.tr/files/ardb/evt/Antimicrobial_resistance:Special_Eurobarometer_407_2013.pdf. Accessed 21 Oct 2015.
34. Fitchett JR, Head MG, Cooke MK, Wurie FB, Atun R. Funding infectious disease research: a systematic analysis of UK research investments by funders 1997-2010. PLoS One. 2014;9(8):e105722. doi: 10.1371/journal.pone.0105722.